These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33472525)

  • 21. An autopsy case of MV2K-type sporadic Creutzfeldt-Jakob disease presenting with characteristic clinical, radiological, and neuropathological findings.
    Matsuo K; Goto D; Hasegawa M; Ogita K; Koyama T; Akagi A; Kitamoto T; Yoshida M; Iwasaki Y
    Neuropathology; 2022 Jun; 42(3):245-253. PubMed ID: 35441383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An autopsy case of Creutzfeldt-Jakob disease with a prion protein gene codon 180 mutation presenting with pathological laughing and an exaggerated startle reaction.
    Iwasaki Y; Mori K; Ito M; Akagi A; Mimuro M; Kitamoto T; Yoshida M
    Neuropathology; 2017 Dec; 37(6):575-581. PubMed ID: 28703419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease.
    Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
    Acta Neuropathol; 2005 Nov; 110(5):490-500. PubMed ID: 16175355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course.
    Niimi Y; Iwasaki Y; Umemura T; Tanaka F; Yoshida M; Hashizume Y; Kitamoto T; Hirayama M; Sobue G
    Neuropathology; 2008 Dec; 28(6):645-51. PubMed ID: 18410280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type.
    Iwasaki Y; Mori K; Ito M; Nagaoka M; Ieda T; Kitamoto T; Yoshida M; Hashizume Y
    Neuropathology; 2011 Oct; 31(5):540-8. PubMed ID: 21269331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of the clinical course and treatment of prion disease patients in the akinetic mutism state in Japan].
    Iwasaki Y; Mori K; Ito M
    Rinsho Shinkeigaku; 2012; 52(5):314-9. PubMed ID: 22688110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autopsy case of V180I genetic Creutzfeldt-Jakob disease presenting with early disease pathology.
    Iwasaki Y; Kato H; Ando T; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
    Neuropathology; 2018 Dec; 38(6):638-645. PubMed ID: 30216556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation between clinical findings and progression of cerebral cortical pathology in MM1-type sporadic Creutzfeldt-Jakob disease: proposed staging of cerebral cortical pathology.
    Iwasaki Y; Tatsumi S; Mimuro M; Kitamoto T; Hashizume Y; Yoshida M
    J Neurol Sci; 2014 Jun; 341(1-2):97-104. PubMed ID: 24787503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.
    Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I
    Prion; 2013; 7(5):383-93. PubMed ID: 24047819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease.
    Iwasaki Y; Hashizume Y; Yoshida M; Kitamoto T; Sobue G
    Acta Neuropathol; 2005 Jun; 109(6):557-66. PubMed ID: 15933870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease.
    Nakatani E; Kanatani Y; Kaneda H; Nagai Y; Teramukai S; Nishimura T; Zhou B; Kojima S; Kono H; Fukushima M; Kitamoto T; Mizusawa H
    Eur J Neurol; 2016 Sep; 23(9):1455-62. PubMed ID: 27222346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An autopsied case of MM1-type sporadic Creutzfeldt-Jakob disease with pathology of Wernicke encephalopathy.
    Iwasaki Y; Hashimoto R; Saito Y; Aiba I; Inukai A; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
    Prion; 2019 Jan; 13(1):13-20. PubMed ID: 30409087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of MM1+2 Creutzfeldt-Jakob disease with a longitudinal study of EEG and MRI].
    Katsube M; Shiota Y; Harada T; Shibata H; Nagai A
    Rinsho Byori; 2013 Nov; 61(11):995-1000. PubMed ID: 24450104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlating diffusion-weighted MRI intensity with type 2 pathology in mixed MM-type sporadic Creutzfeldt-Jakob disease.
    Ikeda T; Iwasaki Y; Sakurai K; Akagi A; Riku Y; Mimuro M; Miyahara H; Kitamoto T; Matsukawa N; Yoshida M
    J Neurol Sci; 2020 Jan; 408():116515. PubMed ID: 31675505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MM2-thalamic-type sporadic Creutzfeldt-Jakob disease with widespread neocortical pathology.
    Hirose K; Iwasaki Y; Izumi M; Yoshida M; Hashizume Y; Kitamoto T; Sahashi K
    Acta Neuropathol; 2006 Oct; 112(4):503-11. PubMed ID: 16957926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological findings of an MM2-cortical-type sporadic Creutzfeldt-Jakob disease patient with cortical blindness during a course of glaucoma and age-related macular degeneration.
    Hayashi Y; Iwasaki Y; Waza M; Shibata H; Akagi A; Kimura A; Inuzuka T; Satoh K; Kitamoto T; Yoshida M; Shimohata T
    Prion; 2019 Jan; 13(1):124-131. PubMed ID: 31219399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients.
    Kobayashi A; Arima K; Ogawa M; Murata M; Fukuda T; Kitamoto T
    Acta Neuropathol; 2008 Nov; 116(5):561-6. PubMed ID: 18751990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyramidal tract degeneration in sporadic Creutzfeldt-Jakob disease.
    Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
    Neuropathology; 2007 Oct; 27(5):434-41. PubMed ID: 18018476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1.
    Kobayashi A; Mizukoshi K; Iwasaki Y; Miyata H; Yoshida Y; Kitamoto T
    Am J Pathol; 2011 Mar; 178(3):1309-15. PubMed ID: 21356381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation.
    Akagi A; Iwasaki Y; Mimuro M; Kitamoto T; Yamada M; Yoshida M
    Prion; 2018 Jan; 12(1):54-62. PubMed ID: 29264994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.